Inovio Pharma Cmn (INO) 9.50 $INO
Inovio Biomedical Set to Possibly Pullback After Yesterday's Rally of 7.39%
Comtex SmarTrend(R) - Mon Sep 12, 2:08PM CDT
Inovio Biomedical (AMEX:INO) traded in a range yesterday that spanned from a low of $8.46 to a high of $9.24. Yesterday, the shares gained 7.4%, which took the trading range above the 3-day high of $9.09 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
INO: 9.50 (-0.24)
Inovio's Zika Vaccine Selected As 2016 Technology Breakthrough
GlobeNewswire - Mon Sep 12, 7:00AM CDT
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that its Zika vaccine in development has been named a 2016 Technology Breakthrough by the editors of Popular Mechanics magazine, the leading technology voice in the U.S. with millions of readers.
INO: 9.50 (-0.24)
The Zacks Analyst Blog Highlights: Inovio Pharmaceuticals, OraSure Technologies, GlaxoSmithKline, Sanofi and Spectrum Brands
Zacks Equity Research - Zacks Investment Research - Wed Sep 07, 8:30AM CDT
The Zacks Analyst Blog Highlights: Inovio Pharmaceuticals, OraSure Technologies, GlaxoSmithKline, Sanofi and Spectrum Brands
INO: 9.50 (-0.24), SPB: 133.07 (-0.79), GSK: 43.42 (-0.16), SNY: 38.35 (-0.22), OSUR: 8.31 (-0.18)
6 Drug Stocks in Focus as Zika Virus Fear Spreads
Arpita Dutt - Zacks Investment Research - Tue Sep 06, 7:00AM CDT
With no vaccines or treatments for Zika, the Zika outbreak is a cause for concern and the company that is the first to come out with a vaccine stands to benefit immensely.
INO: 9.50 (-0.24), SPB: 133.07 (-0.79), GSK: 43.42 (-0.16), SNY: 38.35 (-0.22), OSUR: 8.31 (-0.18)
Inovio Pharmaceuticals to Present at Upcoming Investment Conferences
GlobeNewswire - Thu Sep 01, 8:35AM CDT
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the Company will present a corporate overview at the following upcoming conferences:
INO: 9.50 (-0.24)
These Two Companies Are Working On The Zika Virus Cure
Ryan McQueeney - Zacks Investment Research - Wed Aug 31, 11:57AM CDT
As the Zika virus continues to spread, these two companies are looking to find the cure first.
INO: 9.50 (-0.24), XON: 27.41 (-0.63)
Technical Roundup on Biotech Stocks -- Keryx Biopharma, Inovio Pharma, Seattle Genetics, and Arrowhead Pharma
PR Newswire - Tue Aug 30, 7:15AM CDT
The Biotech arena includes companies that use biological processes to develop technological solutions, and manufacture products intended to improve the quality of life. Stocks under assessment on Stock-Callers.com today are: Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Inovio Pharmaceuticals Inc. (NASDAQ: INO), Seattle Genetics Inc. (NASDAQ: SGEN), and Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR). Sign up today and download for free the research reports for the stocks covered today at:
INO: 9.50 (-0.24), ARWR: 7.22 (-0.05), SGEN: 55.83 (-0.36), KERX: 5.25 (+0.08)
Inovio Stock Up as Second Zika Virus Vaccine Study Begins
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:07AM CDT
Inovio Pharmaceuticals' (INO) shares were up after the company started a second study evaluating its preventive Zika vaccine, GLS-5700, in Puerto Rico.
INO: 9.50 (-0.24), ANIP: 66.64 (-0.17), GERN: 2.20 (-0.02), XON: 27.41 (-0.63)
Business Highlights
By The Associated Press - AP - Mon Aug 29, 5:07PM CDT
WASHINGTON (AP) — ___
INO: 9.50 (-0.24), MDLZ: 43.16 (-0.21), HSY: 95.85 (-0.31), MYL: 42.06 (-0.53), UAL: 50.95 (-0.09)
Herbalife, Wells Fargo gain; Caesars Entertainment sinks
AP - Mon Aug 29, 3:49PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Monday:
INO: 9.50 (-0.24), HLF: 61.23 (+0.30), CF: 22.63 (-0.60), RMD: 63.25 (-0.73), USG: 26.92 (+0.70), WFC: 45.74 (+0.02), CZR: 9.54 (-0.24)
Look for Shares of Inovio Biomedical to Potentially Pullback after Yesterday's 5.87% Rise
Comtex SmarTrend(R) - Mon Aug 29, 3:38PM CDT
Inovio Biomedical (AMEX:INO) traded in a range yesterday that spanned from a low of $9.12 to a high of $9.55. Yesterday, the shares gained 5.9%, which took the trading range above the 3-day high of $9.24 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
INO: 9.50 (-0.24)
Pennsylvania firm launches Zika vaccine trial in Puerto Rico
AP - Mon Aug 29, 1:37PM CDT
SAN JUAN, Puerto Rico (AP) — A Pennsylvania drug company announced Monday that it has launched a clinical trial of an experimental Zika vaccine in Puerto Rico, the part of the U.S. hardest hit by the mosquito-borne virus.
INO: 9.50 (-0.24)
Pol Polyprotein Pipeline Review, H1 2016 Featuring GeoVax Labs, Inovio Pharmaceuticals, & Johnson & Johnson - Research and Markets
BusinessWire - Mon Aug 29, 12:13PM CDT
Research and Markets has announced the addition of the "Pol Polyprotein - Pipeline Review, H1 2016" report to their offering.
JNJ: 118.81 (-0.65), INO: 9.50 (-0.24)
Inovio Launches Zika Vaccine Trial in Midst of Puerto Rico Epidemic to Explore Early Signals of Vaccine Efficacy
GlobeNewswire - Mon Aug 29, 6:00AM CDT
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced it has initiated a clinical study of its preventive Zika vaccine (GLS-5700) in 160 subjects in Puerto Rico, where the Zika virus outbreak has been declared a public health emergency. The CDC estimates Zika will infect more than 25% of the Puerto Rican population by year end, providing the potential for this study's placebo control design to provide exploratory signals of vaccine efficacy.
INO: 9.50 (-0.24)
Inovio (INO) Veterinary Vaccine Rights Licensed to Plumbline
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 7:14AM CDT
Inovio Pharmaceuticals (INO) has licensed its foot and mouth disease vaccine to Plumbline Life Sciences.
INO: 9.50 (-0.24), ANIP: 66.64 (-0.17), GERN: 2.20 (-0.02), ANIK: 46.92 (-1.07)
Inovio Licenses Veterinary Foot and Mouth Disease Vaccine to Plumbline Life Sciences
GlobeNewswire - Tue Aug 16, 7:00AM CDT
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced it has licensed a veterinary vaccine for foot and mouth disease (FMD) to Plumbline Life Sciences (KONEX: 222670), an animal health company headquartered in South Korea. Plumbline will fund all development activities for this FMD vaccine. Inovio will receive milestone payments as well as royalties on product sales from Plumbline for commercial rights to this FMD synthetic vaccine in Asia, excluding Japan. In 2014, Inovio sold other animal health assets to Plumbline for cash and a significant equity position in the company.
INO: 9.50 (-0.24)
Inovio Expands Enrollment in Ebola Vaccine Phase I Study
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 9:38AM CDT
Inovio Pharmaceuticals (INO) has expanded a phase I Ebola vaccine study to identify the most optimal immunization regimen.
INO: 9.50 (-0.24), JNJ: 118.81 (-0.65), MRK: 62.96 (-0.06), GSK: 43.42 (-0.16)
Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial to Identify Most Optimal Immunization Regimen
GlobeNewswire - Thu Aug 11, 7:00AM CDT
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the company is more than doubling study enrollment to further characterize and identify in humans the most optimal immunization regimen using intradermal (skin) delivery of its preventive Ebola DNA vaccine. Inovio is enrolling 125 subjects in a second stage of its phase I trial of INO-4212 after generating positive initial safety and immune response data in the first set of 75 healthy volunteers. The study will assess immune response characteristics generated with fewer intradermal administrations, lower doses, and with and without its DNA-based IL-12 immune activator.
INO: 9.50 (-0.24)
Zika Virus and Today's Stock Market
Mark Vickery - Zacks Investment Research - Wed Aug 10, 9:07AM CDT
As Inovio Pharma (INO) works to eradicate the Zika virus on U.S. shores and beyond, what does it mean for Florida companies like Disney (DIS), which reported higher quarterly results?
INO: 9.50 (-0.24), DIS: 93.27 (-0.14), KORS: 50.51 (+0.40), YELP: 39.38 (+0.92), RL: 99.91 (+0.94), WEN: 10.83 (+0.06)
Inovio Biomedical Set to Possibly Pullback After Yesterday's Rally of 7.39%
Comtex SmarTrend(R) - Mon Sep 12, 2:08PM CDT
Inovio Biomedical (AMEX:INO) traded in a range yesterday that spanned from a low of $8.46 to a high of $9.24. Yesterday, the shares gained 7.4%, which took the trading range above the 3-day high of $9.09 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
INO: 9.50 (-0.24)
Inovio's Zika Vaccine Selected As 2016 Technology Breakthrough
GlobeNewswire - Mon Sep 12, 7:00AM CDT
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that its Zika vaccine in development has been named a 2016 Technology Breakthrough by the editors of Popular Mechanics magazine, the leading technology voice in the U.S. with millions of readers.
INO: 9.50 (-0.24)
The Zacks Analyst Blog Highlights: Inovio Pharmaceuticals, OraSure Technologies, GlaxoSmithKline, Sanofi and Spectrum Brands
Zacks Equity Research - Zacks Investment Research - Wed Sep 07, 8:30AM CDT
The Zacks Analyst Blog Highlights: Inovio Pharmaceuticals, OraSure Technologies, GlaxoSmithKline, Sanofi and Spectrum Brands
INO: 9.50 (-0.24), SPB: 133.07 (-0.79), GSK: 43.42 (-0.16), SNY: 38.35 (-0.22), OSUR: 8.31 (-0.18)
6 Drug Stocks in Focus as Zika Virus Fear Spreads
Arpita Dutt - Zacks Investment Research - Tue Sep 06, 7:00AM CDT
With no vaccines or treatments for Zika, the Zika outbreak is a cause for concern and the company that is the first to come out with a vaccine stands to benefit immensely.
INO: 9.50 (-0.24), SPB: 133.07 (-0.79), GSK: 43.42 (-0.16), SNY: 38.35 (-0.22), OSUR: 8.31 (-0.18)
Inovio Pharmaceuticals to Present at Upcoming Investment Conferences
GlobeNewswire - Thu Sep 01, 8:35AM CDT
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the Company will present a corporate overview at the following upcoming conferences:
INO: 9.50 (-0.24)
These Two Companies Are Working On The Zika Virus Cure
Ryan McQueeney - Zacks Investment Research - Wed Aug 31, 11:57AM CDT
As the Zika virus continues to spread, these two companies are looking to find the cure first.
INO: 9.50 (-0.24), XON: 27.41 (-0.63)
Technical Roundup on Biotech Stocks -- Keryx Biopharma, Inovio Pharma, Seattle Genetics, and Arrowhead Pharma
PR Newswire - Tue Aug 30, 7:15AM CDT
The Biotech arena includes companies that use biological processes to develop technological solutions, and manufacture products intended to improve the quality of life. Stocks under assessment on Stock-Callers.com today are: Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Inovio Pharmaceuticals Inc. (NASDAQ: INO), Seattle Genetics Inc. (NASDAQ: SGEN), and Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR). Sign up today and download for free the research reports for the stocks covered today at:
INO: 9.50 (-0.24), ARWR: 7.22 (-0.05), SGEN: 55.83 (-0.36), KERX: 5.25 (+0.08)
Inovio Stock Up as Second Zika Virus Vaccine Study Begins
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:07AM CDT
Inovio Pharmaceuticals' (INO) shares were up after the company started a second study evaluating its preventive Zika vaccine, GLS-5700, in Puerto Rico.
INO: 9.50 (-0.24), ANIP: 66.64 (-0.17), GERN: 2.20 (-0.02), XON: 27.41 (-0.63)
Business Highlights
By The Associated Press - AP - Mon Aug 29, 5:07PM CDT
WASHINGTON (AP) — ___
INO: 9.50 (-0.24), MDLZ: 43.16 (-0.21), HSY: 95.85 (-0.31), MYL: 42.06 (-0.53), UAL: 50.95 (-0.09)
Herbalife, Wells Fargo gain; Caesars Entertainment sinks
AP - Mon Aug 29, 3:49PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Monday:
INO: 9.50 (-0.24), HLF: 61.23 (+0.30), CF: 22.63 (-0.60), RMD: 63.25 (-0.73), USG: 26.92 (+0.70), WFC: 45.74 (+0.02), CZR: 9.54 (-0.24)
Look for Shares of Inovio Biomedical to Potentially Pullback after Yesterday's 5.87% Rise
Comtex SmarTrend(R) - Mon Aug 29, 3:38PM CDT
Inovio Biomedical (AMEX:INO) traded in a range yesterday that spanned from a low of $9.12 to a high of $9.55. Yesterday, the shares gained 5.9%, which took the trading range above the 3-day high of $9.24 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
INO: 9.50 (-0.24)
Pennsylvania firm launches Zika vaccine trial in Puerto Rico
AP - Mon Aug 29, 1:37PM CDT
SAN JUAN, Puerto Rico (AP) — A Pennsylvania drug company announced Monday that it has launched a clinical trial of an experimental Zika vaccine in Puerto Rico, the part of the U.S. hardest hit by the mosquito-borne virus.
INO: 9.50 (-0.24)
Pol Polyprotein Pipeline Review, H1 2016 Featuring GeoVax Labs, Inovio Pharmaceuticals, & Johnson & Johnson - Research and Markets
BusinessWire - Mon Aug 29, 12:13PM CDT
Research and Markets has announced the addition of the "Pol Polyprotein - Pipeline Review, H1 2016" report to their offering.
JNJ: 118.81 (-0.65), INO: 9.50 (-0.24)
Inovio Launches Zika Vaccine Trial in Midst of Puerto Rico Epidemic to Explore Early Signals of Vaccine Efficacy
GlobeNewswire - Mon Aug 29, 6:00AM CDT
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced it has initiated a clinical study of its preventive Zika vaccine (GLS-5700) in 160 subjects in Puerto Rico, where the Zika virus outbreak has been declared a public health emergency. The CDC estimates Zika will infect more than 25% of the Puerto Rican population by year end, providing the potential for this study's placebo control design to provide exploratory signals of vaccine efficacy.
INO: 9.50 (-0.24)
Inovio (INO) Veterinary Vaccine Rights Licensed to Plumbline
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 7:14AM CDT
Inovio Pharmaceuticals (INO) has licensed its foot and mouth disease vaccine to Plumbline Life Sciences.
INO: 9.50 (-0.24), ANIP: 66.64 (-0.17), GERN: 2.20 (-0.02), ANIK: 46.92 (-1.07)
Inovio Licenses Veterinary Foot and Mouth Disease Vaccine to Plumbline Life Sciences
GlobeNewswire - Tue Aug 16, 7:00AM CDT
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced it has licensed a veterinary vaccine for foot and mouth disease (FMD) to Plumbline Life Sciences (KONEX: 222670), an animal health company headquartered in South Korea. Plumbline will fund all development activities for this FMD vaccine. Inovio will receive milestone payments as well as royalties on product sales from Plumbline for commercial rights to this FMD synthetic vaccine in Asia, excluding Japan. In 2014, Inovio sold other animal health assets to Plumbline for cash and a significant equity position in the company.
INO: 9.50 (-0.24)
Inovio Expands Enrollment in Ebola Vaccine Phase I Study
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 9:38AM CDT
Inovio Pharmaceuticals (INO) has expanded a phase I Ebola vaccine study to identify the most optimal immunization regimen.
INO: 9.50 (-0.24), JNJ: 118.81 (-0.65), MRK: 62.96 (-0.06), GSK: 43.42 (-0.16)
Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial to Identify Most Optimal Immunization Regimen
GlobeNewswire - Thu Aug 11, 7:00AM CDT
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the company is more than doubling study enrollment to further characterize and identify in humans the most optimal immunization regimen using intradermal (skin) delivery of its preventive Ebola DNA vaccine. Inovio is enrolling 125 subjects in a second stage of its phase I trial of INO-4212 after generating positive initial safety and immune response data in the first set of 75 healthy volunteers. The study will assess immune response characteristics generated with fewer intradermal administrations, lower doses, and with and without its DNA-based IL-12 immune activator.
INO: 9.50 (-0.24)
Zika Virus and Today's Stock Market
Mark Vickery - Zacks Investment Research - Wed Aug 10, 9:07AM CDT
As Inovio Pharma (INO) works to eradicate the Zika virus on U.S. shores and beyond, what does it mean for Florida companies like Disney (DIS), which reported higher quarterly results?
INO: 9.50 (-0.24), DIS: 93.27 (-0.14), KORS: 50.51 (+0.40), YELP: 39.38 (+0.92), RL: 99.91 (+0.94), WEN: 10.83 (+0.06)
